In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.

Samankaltaisia teoksia

• Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.
  Tekijä: Belanger, P, et al.
  Julkaistu: (1997)
• A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
  Tekijä: Sanati, H, et al.
  Julkaistu: (1997)
• In Vitro Activities of Voriconazole (UK-109,496) and Four Other Antifungal Agents against 394 Clinical Isolates of Candida spp.
  Tekijä: Marco, F., et al.
  Julkaistu: (1998)
• In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
  Tekijä: Radford, S A, et al.
  Julkaistu: (1997)
• In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
  Tekijä: Ruhnke, M, et al.
  Julkaistu: (1997)